デフォルト表紙
市場調査レポート
商品コード
1022165

塞栓防止装置市場:世界の産業動向、シェア、規模、成長、機会、予測(2021~2026年)

Embolic Protection Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

出版日: | 発行: IMARC Services Private Limited | ページ情報: 英文 147 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.72円
塞栓防止装置市場:世界の産業動向、シェア、規模、成長、機会、予測(2021~2026年)
出版日: 2021年08月02日
発行: IMARC Services Private Limited
ページ情報: 英文 147 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

世界の塞栓防止装置の市場規模は、2015年から2020年にかけて力強い成長を示しました。今後、2021年から2026年の間に8.4%のCAGRで拡大すると予測されています。

塞栓防止装置(EPD)は、ステント留置中に伏在静脈グラフト(SVG)内の血液や管腔内の破片を捕捉し、遠位部の塞栓を防止します。これらのデバイスには、遠位部閉塞デバイス、遠位部フィルター、近位部閉塞デバイスの3つのクラスがあります。これらのデバイスは、SVGインターベンション、経皮的冠動脈インターベンション、大動脈弁狭窄症などの外科的処置の際に外れる可能性のある破片を捕捉して除去することにより、術後の心筋梗塞や主要な心血管有害事象を減少させる最も検証された戦略を提供します。

心血管疾患(CVD)の増加は、市場成長の主な要因の一つです。EPDは、血流中に放出された破片による小血管の閉塞に起因する合併症を減らすために非常に重要です。EPDは、心筋梗塞やその他の主要な心血管イベントを減少させるための、最も信頼性の高い、エビデンスに基づく手順の一部を構成しています。このことは、心停止やその他の心臓関連の問題が増加していることと相まって、EPDの市場を大きく押し上げています。さらに、世界各国の政府は、研究開発能力の向上に投資しており、これも大きな成長要因となっています。また、慢性疾患にかかりやすい高齢者人口が世界的に増加していることも、市場の成長に寄与しています。また、低侵襲製品への需要の高まりや、いくつかの技術的進歩、医療分野の著しい成長なども、市場に好影響を与える要因の一つと考えられます。

当レポートでは、塞栓防止装置市場について調査し、市場の概要とともに、製品別、用途別、手技別、材料別、使用法別、エンドユーザー別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 序文

第2章 範囲と調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界の塞栓防止装置市場

  • 市場概要
  • 市場パフォーマンス
  • COVID-19の影響

第6章 市場セグメンテーション、製品別

  • 遠位フィルター装置
  • 遠位閉塞装置
  • 近位閉塞装置

第7章 市場セグメンテーション、用途別

  • 冠状動脈治療
  • 頸動脈治療
  • その他

第8章 市場セグメンテーション、手技別

  • 経皮的冠動脈インターベンション
  • 頸動脈狭窄症
  • 伏在静脈グラフト介入
  • 大動脈弁狭窄症(経カテーテル大動脈弁置換術)
  • その他

第9章 市場セグメンテーション、材料別

  • ニチノール
  • ポリウレタン

第10章 市場セグメンテーション、使用法別

  • ディスポーザブルデバイス
  • リユーザブルデバイス

第11章 市場セグメンテーション、エンドユーザー別

  • 病院および診療所
  • 外来手術センター
  • その他

第12章 市場セグメンテーション、地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東とアフリカ
    • 国別の市場セグメンテーション

第13章 SWOT分析

第14章 バリューチェーン分析

第15章 ポーターズファイブフォース分析

第16章 価格指標

第17章 競合情勢

  • 市場構造
  • キープレーヤー
  • キープレーヤーのプロファイル
    • Abbott Laboratories
    • Allium Medical Solutions Ltd.
    • Boston Scientific Corporation
    • Cardinal Health Inc.
    • Contego Medical LLC
    • Innovative Cardiovascular Solutions LLC
    • Edwards Lifesciences Corporation
    • Medtronic Inc.
    • Silk Road Medical Inc.
目次
Product Code: SR1020E231_Report

The global embolic protection devices market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 8.4% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Embolic protection devices (EPD) trap blood and luminal debris within the saphenous vein graft (SVG) during stenting to prevent distal embolization. There are three classes of these devices, including distal occlusion devices, distal filters and proximal occlusion devices. These devices provide the most verified strategy to reduce periprocedural myocardial infarction (MI) and major adverse cardiovascular events by capturing and removing debris that may get dislodged during surgical procedures such as SVG interventions, percutaneous coronary intervention, aortic valve stenosis, etc..

The increasing prevalence of cardiovascular diseases (CVDs) represent one of the key factors driving the market growth. EPDs are crucial in reducing complications arising due to blockages in small blood vessels caused by the debris that is released into the bloodstream. They form a part of the most reliable, evidence-based procedure for reducing periprocedural MI and other major cardiovascular events. This, coupled with increasing instances of cardiac arrests and other heart-related issues, is providing a significant boost to the market for EPDs. Furthermore, governments of several nations across the globe are investing in increasing their research and development (R&D) capabilities, which is acting as another major growth-inducing factor. Steadily increasing geriatric population across the world, which is more susceptible to chronic medical illnesses, is also contributing to the market growth. The rising demand for minimally invasive products and several technological advancements, along with the significant growth in the healthcare sector, are some of the other factors that are expected to further create a positive outlook for the market.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global embolic protection devices market report, along with forecasts for growth at the global, regional and country-level from 2021-2026. Our report has categorized the market based on region, product, application, procedure, material, usage, and end-user.

Breakup by Product:

  • Distal Filter Devices
  • Distal Occlusion Devices
  • Proximal Occlusion Devices

Breakup by Application:

  • Coronary Artery Treatment
  • Carotid Artery Treatment
  • Others

Breakup by Procedure:

  • Percutaneous Coronary Intervention
  • Carotid Artery Stenosis
  • Saphenous Vein Graft Intervention
  • Aortic Valve Stenosis (Transcatheter Aortic Valve Replacement)
  • Others

Breakup by Material:

  • Nitinol
  • Polyurethane

Breakup by Usage:

  • Disposable Devices
  • Re-Usable Devices

Breakup by End-User:

  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Abbott Laboratories, Allium Medical Solutions Ltd., Boston Scientific Corporation, Cardinal Health Inc., Contego Medical LLC, Innovative Cardiovascular Solutions LLC, Edwards Lifesciences Corporation, Medtronic Inc., Silk Road Medical Inc., etc. Key Questions Answered in This Report:

  • How has the global embolic protection devices market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the global embolic protection devices market?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the procedure?
  • What is the breakup of the market based on the material?
  • What is the breakup of the market based on the usage?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global embolic protection devices market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Embolic Protection Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Distal Filter Devices
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Distal Occlusion Devices
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Proximal Occlusion Devices
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Coronary Artery Treatment
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Carotid Artery Treatment
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Procedure

  • 8.1 Percutaneous Coronary Intervention
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Carotid Artery Stenosis
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Saphenous Vein Graft Intervention
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Aortic Valve Stenosis (Transcatheter Aortic Valve Replacement)
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Material

  • 9.1 Nitinol
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Polyurethane
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by Usage

  • 10.1 Disposable Devices
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Re-Usable Devices
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast

11 Market Breakup by End-User

  • 11.1 Hospitals and Clinics
    • 11.1.1 Market Trends
    • 11.1.2 Market Forecast
  • 11.2 Ambulatory Surgical Centers
    • 11.2.1 Market Trends
    • 11.2.2 Market Forecast
  • 11.3 Others
    • 11.3.1 Market Trends
    • 11.3.2 Market Forecast

12 Market Breakup by Region

  • 12.1 North America
    • 12.1.1 United States
      • 12.1.1.1 Market Trends
      • 12.1.1.2 Market Forecast
    • 12.1.2 Canada
      • 12.1.2.1 Market Trends
      • 12.1.2.2 Market Forecast
  • 12.2 Asia Pacific
    • 12.2.1 China
      • 12.2.1.1 Market Trends
      • 12.2.1.2 Market Forecast
    • 12.2.2 Japan
      • 12.2.2.1 Market Trends
      • 12.2.2.2 Market Forecast
    • 12.2.3 India
      • 12.2.3.1 Market Trends
      • 12.2.3.2 Market Forecast
    • 12.2.4 South Korea
      • 12.2.4.1 Market Trends
      • 12.2.4.2 Market Forecast
    • 12.2.5 Australia
      • 12.2.5.1 Market Trends
      • 12.2.5.2 Market Forecast
    • 12.2.6 Indonesia
      • 12.2.6.1 Market Trends
      • 12.2.6.2 Market Forecast
    • 12.2.7 Others
      • 12.2.7.1 Market Trends
      • 12.2.7.2 Market Forecast
  • 12.3 Europe
    • 12.3.1 Germany
      • 12.3.1.1 Market Trends
      • 12.3.1.2 Market Forecast
    • 12.3.2 France
      • 12.3.2.1 Market Trends
      • 12.3.2.2 Market Forecast
    • 12.3.3 United Kingdom
      • 12.3.3.1 Market Trends
      • 12.3.3.2 Market Forecast
    • 12.3.4 Italy
      • 12.3.4.1 Market Trends
      • 12.3.4.2 Market Forecast
    • 12.3.5 Spain
      • 12.3.5.1 Market Trends
      • 12.3.5.2 Market Forecast
    • 12.3.6 Russia
      • 12.3.6.1 Market Trends
      • 12.3.6.2 Market Forecast
    • 12.3.7 Others
      • 12.3.7.1 Market Trends
      • 12.3.7.2 Market Forecast
  • 12.4 Latin America
    • 12.4.1 Brazil
      • 12.4.1.1 Market Trends
      • 12.4.1.2 Market Forecast
    • 12.4.2 Mexico
      • 12.4.2.1 Market Trends
      • 12.4.2.2 Market Forecast
    • 12.4.3 Others
      • 12.4.3.1 Market Trends
      • 12.4.3.2 Market Forecast
  • 12.5 Middle East and Africa
    • 12.5.1 Market Trends
    • 12.5.2 Market Breakup by Country
    • 12.5.3 Market Forecast

13 SWOT Analysis

  • 13.1 Overview
  • 13.2 Strengths
  • 13.3 Weaknesses
  • 13.4 Opportunities
  • 13.5 Threats

14 Value Chain Analysis

15 Porters Five Forces Analysis

  • 15.1 Overview
  • 15.2 Bargaining Power of Buyers
  • 15.3 Bargaining Power of Suppliers
  • 15.4 Degree of Competition
  • 15.5 Threat of New Entrants
  • 15.6 Threat of Substitutes

16 Price Indicators

17 Competitive Landscape

  • 17.1 Market Structure
  • 17.2 Key Players
  • 17.3 Profiles of Key Players
    • 17.3.1 Abbott Laboratories
      • 17.3.1.1 Company Overview
      • 17.3.1.2 Product Portfolio
      • 17.3.1.3 Financials
      • 17.3.1.4 SWOT Analysis
    • 17.3.2 Allium Medical Solutions Ltd.
      • 17.3.2.1 Company Overview
      • 17.3.2.2 Product Portfolio
      • 17.3.2.3 Financials
    • 17.3.3 Boston Scientific Corporation
      • 17.3.3.1 Company Overview
      • 17.3.3.2 Product Portfolio
      • 17.3.3.3 Financials
      • 17.3.3.4 SWOT Analysis
    • 17.3.4 Cardinal Health Inc.
      • 17.3.4.1 Company Overview
      • 17.3.4.2 Product Portfolio
      • 17.3.4.3 Financials
      • 17.3.4.4 SWOT Analysis
    • 17.3.5 Contego Medical LLC
      • 17.3.5.1 Company Overview
      • 17.3.5.2 Product Portfolio
    • 17.3.6 Innovative Cardiovascular Solutions LLC
      • 17.3.6.1 Company Overview
      • 17.3.6.2 Product Portfolio
    • 17.3.7 Edwards Lifesciences Corporation
      • 17.3.7.1 Company Overview
      • 17.3.7.2 Product Portfolio
      • 17.3.7.3 Financials
      • 17.3.7.4 SWOT Analysis
    • 17.3.8 Medtronic Inc.
      • 17.3.8.1 Company Overview
      • 17.3.8.2 Product Portfolio
      • 17.3.8.3 Financials
      • 17.3.8.4 SWOT Analysis
    • 17.3.9 Silk Road Medical Inc.
      • 17.3.9.1 Company Overview
      • 17.3.9.2 Product Portfolio
      • 17.3.9.3 Financials